Chemistry: molecular biology and microbiology – Treatment of micro-organisms or enzymes with electrical or... – Modification of viruses
Reexamination Certificate
2005-12-13
2005-12-13
Park, Hankyel T. (Department: 1648)
Chemistry: molecular biology and microbiology
Treatment of micro-organisms or enzymes with electrical or...
Modification of viruses
C435S005000, C435S006120, C435S325000, C424S206100, C424S159100, C536S023720
Reexamination Certificate
active
06974686
ABSTRACT:
Recombinant PB2 tryptophan variant influenza viruses, RNA, cDNA and vectors are provided. Also provided are immunogenic compositions containing the variant viruses, methods of producing such viruses and methods for the prophylactic treatment of influenza in humans.
REFERENCES:
patent: 6090391 (2000-07-01), Parkin
Nakagawa, The RNA Polymerase PB2 Subunit Is Not Required for Replication of the Influenza Virus Genome but is Involved in Capped mRNA Synthesis, Feb. 1995, J Virol 69(2):728-33.
Schonberger, Guillain-Barre syndrome: its epidemiology and associations with influenza vaccination, 1981, Annals of Neurology 9 Suppl:31-8.
Murphy, Use of Live Attentuated Cold-Adapted Influenza A Reassortant Virus Vaccines in Infants, children, Young Adults, and Elderly Adults, 1993, Inf Dis in Clin Prac 2:174-81.
Murphy & Chanock, Genetic Approaches to the Prevention of Influenza A Virus Infection, 1981, Genetic Variation Among Influenza Viruses, Academic Press, pp601-14.
Murphy, Genetic approaches to attenuatiaon of influenza A viruses for man, 1980, Phil Trans R Soc Lond B 288:401-15.
Murphy, Escape of a Highly Defective Influenza A Virus Mutant From Its Temperature Sensitive Phenotype by Extragenic Suppression and Other Types of Mutation, 1980, Annals NY Acad Sci, pp172-82.
Tolpin, Evaluation of a Phenotypic Repentant of the A/Alaska/77-ts-1A2 Reassortant Virus in Hamsters and in Seronegative Adult Volunteers etc, 1982, Infection and Immunity 36(2):645-50.
Lawson, Nucleotide Sequence Changes in the Polymerase Basic Protein 2 Gene of Temperature-Sensitive Mutants of Influenza A Virus, 1992, Virology 191:506-10.
Enami, Introduction of site-specific mutations into the genome of influenza virus, 1990, Proc Natl Acad Sci 87:3802-05.
Enami and Palese, High-Efficiency Formation of Influenza Virus Transfectants, 1991, J Virol 65(5):2711-13.
Luytjes, Amplification, Expression and packaging of a Foreign Gene by Influenza Virus, 1989, Cell 59:1107-13.
Horimoto, Reverse Genetics Provides Direct Evidence for a Correlation of Hemagglutinin Cleavability and Virulence of an Avian Influenza A Virus, 1994, J Virol 68(5):3120-28.
Li, Influenza A Virus Transfectants with Chimeric Hemagglutinins containing Epitopes from Different Subtypes, 1992, J Virol 66(1):399-404.
Barclay, Influenza B Viruses with Site-Specific Mutations Introduced into the HA Gene, Feb. 1995, J Virol 69(2):1275-79.
Yasuda, Growth Control of Influenza A Virus by M1 Protein etc, 1994, J Virol 68(12):8141-46.
Ishida, The Stacking Interactions in 7-Methylguanine-Tryptophan systems etc, 1983, Biochem and Biophys Res Comm 115(3):849-54.
Altmann, Site-directed Mutagenesis of the Tryptophan Residues in Yeast Eukaryotic Initiation Factor 4E, 1988, J Biol Chem 263(33):17229-32.
de la Luna, Molecular cloning and sequencing of influenza virus A/Victoria/3/75 polymerase genes etc, 1989, Virus Res 13:143-55.
Perales, Mutational Analysis Identifies Functional Domains in the Influenze A virus PB2 Polymerase Subunit, Mar. 1996, J Virol. 70(3):1678-86.
Hassett, Targeted construction of temperature-sensitive mutations in vaccinia virus by replacing clustered charged residues with alanine, 1994, Proc Natl Acad Sci 91:4554-58.
Wiskerchen, Identification and characterization of a Temperature Sensitive Mutant of Human Immunodeficiency Virus Type 1 by Alanine Scanning Mutagenesis of the Integrase Gene, Jan. 1995, J Virol 69(1):597-601.
Diamond, Clustered Charged-to-alanine Mutagenesis of Poliovirus RNA-Dependent RNA Polymerase Yields Multiple Temperature-Sensitive Mutants Defective in RNA Synthesis, 1994, J Virol 68(2):863-876.
Plotch, A unique Cap(m7GpppXm)-Dependent Influenza Virion Endonuclease Cleaves Capped RNAs to Generate the Primers That Initiate Viral RNA Transcription, 1981, Cell 23:847-58.
Powers, Reduced Infectivity of Cold-Adapted Influenza A H1N1 Viruses in the Elderly etc, 1992, J Am Ger Soc 40:163-67.
Li, Electroporation of influenza virus ribonucleoprotein complexes for rescue of the nucleoprotein and natrix genes, 1995, Virus Res 37:153-61.
Sonenberg, Cap-Binding Proteins of Eukaryotic Messenger RNA etc, 1988, Prog Nucleic Acid Res Mol Biol 35:173-207.
MedImmune Vaccines, Inc.
Park Hankyel T.
LandOfFree
Recombinant tryptophan mutants of influenza does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Recombinant tryptophan mutants of influenza, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Recombinant tryptophan mutants of influenza will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3515870